Optimization of a type III secretion system-based Pseudomonas aeruginosa live vector for antigen delivery

Clinical and Vaccine Immunology

Volumn 15, Issue 2, 2008, Pages 308-313

  Epaulard, Olivier ^a   Derouazi, Madiha ^a   Margerit, Carole ^a   Marlu, Raphaël ^a   Filopon, Didier ^a   Polack, Benoît ^a,b   Toussaint, Bertrand ^a  

^a LABORATOIRE TIMC IMAG   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; CD8 ANTIGEN; OVALBUMIN; BACTERIAL VACCINE; LIVE VACCINE; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; AROA GENE; ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CANCER MODEL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENE DELETION; GENE MUTATION; IMMUNE RESPONSE; IMMUNOTHERAPY; LETHAL DOSE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; TYPE III SECRETION SYSTEM; ANIMAL; C57BL MOUSE; DOSE RESPONSE; GENETICS; IMMUNOLOGY; LD 50; METABOLISM; PATHOGENICITY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; BACTERIAL VACCINES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENE DELETION; GENES, BACTERIAL; LETHAL DOSE 50; MICE; MICE, INBRED C57BL; OVALBUMIN; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; VACCINES, ATTENUATED; VIRULENCE FACTORS;

EID: 40449119079     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00278-07     Document Type: Article

References (27)

1. Abd El Ghany, M., A. Jansen, S. Clare, L. Hall, D. Pickard, R. A. Kingsley, and G. Dougan. 2007. Candidate live, attenuated Salmonella enterica serovar Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines. Infect. Immun. 75:1835-1842.
2. Bleves, S., C. Soscia, P. Nogueira-Orlandi, A. Lazdunski, and A. Filloux. 2005. Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J. Bacteriol. 187:3898-3902.
3. Brown D. M., T. L. Fisher, C. Wei, J. G. Frelinger, and E. M. Lord. 2001. Tumours can act as adjuvants for humoral immunity. Immunology 102:486-497.
4. Buzzola, F. R., M. S. Barbagelata, R. L. Caccuri, and D. O. Sordelli. 2006. Attenuation and persistence of and ability to induce protective immunity to a Staphylococcus aureus aroA mutant in mice. Infect. Immun. 74:3498-3506.
5. Chabalgoity, J. A., G. Dougan, P. Mastroeni, and R. J. Aspinall. 2002. Live bacteria as the basis for immunotherapies against cancer. Expert Rev. Vaccines 1:495-505.
6. Coley, W. B. 1893. The treatment of malignant tumours by repeated inoculations of erysipelas, with a report of ten original cases. Am. J. Med. Sci. 105:487-511.
7. Dacheux, D., O. Epaulard, A. de Groot, B. Guery, R. Le Berre, I. Attree, B. Polack, and B. Toussaint. 2002. Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon. Infect. Immun. 70:3973-3977.
8. Epaulard, O., B. Toussaint, L. Quénée, M. Derouazi, N. Bosco, C. Villiers, R. Le Berre, B. Guery, D. Filopon, L. Crombez, P. Marche, and B. Polack. 2006. Anti-tumour immunotherapy using a live Pseudomonas aeruginosa type III secretion system-based vector in a mouse model. Mol. Ther. 14:656-661.
9. Filopon, D., A. Merieau, G. Bernot, J. P. Comet, R. Le Berre, B. Guery, B. Polack, and J. Guespin-Michel. 2006. Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa. BMC Bioinformatics 7:272.
10. Fittipaldi, N., J. Harel, B. D'Amours, S. Lacouture, M. Kobisch, and M. Gottschalk. 2007. Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine. Vaccine 25:3524-3535.
11. Hogardt, M., M. Roeder, A. M. Schreff, L. Eberl, and J. Heesemann. 2004. Expression of Pseudomonas aeruginosa ExoS in controlled by quorum sensing and RpoS. Microbiology 150:843-851.
12. Kotton, C. N., A. J. Lankowski, N. Scott, D. Sisul, L. M Chen, K. Raschke, G. Borders, M. Boaz, A. Spentzou, J. E. Galan, and E. L. Hohmann. 2006. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella type III secretion system. Vaccine 24:6216-6224.
13. Lesic, B., F. Lépine, E. Déziel, J. Zhang, Q. Zhang, K. Padfield, M. H. Castonguay, S. Milot, S. Stachel, A. A. Tzika, R. G. Tompkins, and L. G. Rahme. 2007. Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog. 3:1229-1239.
14. Lesprit, P., F. Faurisson, O. Join-Lambert, F. Roudot-Thoraval, M. Foglino, C. Vissuzaine, and C. Carbon. 2003. Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am. J. Respir. Crit. Care Med. 167:1478-1482.
15. Mittal, R., S. Sharma, S. Shhibber, and K. Harjai. 2006. Contribution of quorum-sensing systems to virulence of Pseudomonas aeruginosa in an experimental pyelonephritis model. J. Microbiol. Immunol. Infect. 39:302-309.
16. Nishikawa, H., E. Sato, G. Briones, L. M. Chen, M. Matsuo, Y. Nagata, G. Ritter, E. Jager, H. Nomura, S. Kondo, I. Tawara, T. Kato, H. Shiku, J. Old, J. E. Galan, and S. Gnatic. 2006. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. J. Clin. Investig. 116:1946-1954.
17. Panthel, K., K. M. Meinel, V. E. Domenech, H. Retzbach, E. I. Igwe, W. D. Hardt, and H. Russmann. 2005. Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells. Infect. Immun. 73:334-341.
18. Pearson J. P., M. Feldman, B. H. Iglewski, and A. Prince. 2000. Pseudomonas aeruginosa cell-to-cell signalling is required for virulence in a model of acute pulmonary infection. Infect. Immun. 68:4331-4334.
19. Priebe, G. P., G. J. Meluleni, F. T. Coleman, J. B. Goldberg, and G. B. Pier. 2003. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect. Immun. 71:1453-1461.
20. Quénée, L., D. Lamotte, and B. Polack. 2005. Combined sacB-based negative selection and Cre-lox antibiotic marker recycling for efficient gene deletion in Pseudomonas aeruginosa. BioTechniques 38:63-67.
21. Radford, K. J., D. E. Higgins, S. Pasquini, E. J. Cheadle, L. Carta, A. M. Jackson, N. R. Lemoine, and G. Vassaux. 2002. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Ther. 9:1455-1463.
22. Ritchie, A. J., A. Jansson, J. Stallberg, P. Nilsson, P. Lysaght, and M. A. Cooley. 2005. The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L-homoserine lactone inhibits T-cell differentiation and cytokine production by a mechanism involving an early step in T-cell activation. Infect. Immun. 71:1648-1655.
23. Rumbaugh, K. P., J. A. Griswold, B. H. Iglewski, and A. N. Hamood. 1999. Contribution of QS to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect. Immun. 67:5854-5862.
24. Russmann, H., U. Gerdemann, E. I. Igwe, K. Panthel, J. Heesemann, S. Garbom, H. Wolf-Watz, and G. Geginat. 2003. Attenuated Yersinia pseudo-tuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction. Infect. Immun. 71:3463-3472.
25. Telford, G., D. Wheeler, P. Williams, P. T. Tomkins, P. Appleby, H. Sewell, G. S. A. B. Stewart, B. W. Bycroft, and D. I. Pritchard. 1998. The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxodode-canoyl)-L-homoserine lactone has immunomodulatory activity. Infect. Immun. 66:36-42.
26. Vivas, J., J. Riano, B. Carracedo, B. E. Razquin, P. Lopez-Fierro, G. Naharro, and A. J. Villena. 2004. The auxotrophic aroA mutant of Aeromonas hydrophila as a live attenuated vaccine against A. salmonicida infections in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 16:193-206.
27. Reference deleted.